1
Extension Study of Fesoterodine for Overactive Bladder Syndrome in Children.
Condition(s):Overactive BladderLast Updated:July 30, 2019Completed
Fesoterodine as an Intervention: 76 Clinical Trials, Page 1 of 8
Hide Studies Not Open or Pending
2
Post Marketing Surveillance Of Fesoterodine In Filipino Patients With Over Active Bladder
Condition(s):Over Active BladderLast Updated:September 11, 2014Completed
3
Local, Open-Label, Extension Trial Of The Efficacy And Safety Of Fesoterodine In Elderly Patients With Overactive Bladder
Condition(s):Urinary Bladder, OveractiveLast Updated:May 15, 2013Completed
4
Fesoterodine for Amelioration of Autonomic Dysreflexia (AD) Following Spinal Cord Injury (SCI)
Condition(s):Autonomic DysreflexiaLast Updated:September 9, 2019Completed
5
Fesoterodine on Urgency Episodes in Parkinson’s Disease Population
Condition(s):Urinary Bladder, Overactive; Parkinson DiseaseLast Updated:September 26, 2019Terminated
6
Evaluation Of The Ability Of Fesoterodine To Increase Urethral Pressure In Stress Urinary Incontinence Patients
Condition(s):Stress Urinary IncontinenceLast Updated:July 22, 2011Completed
7
Understanding the Response to Fesoterodine Through Genetic Evaluation in the Elderly (URGE)
Condition(s):Urge Urinary IncontinenceLast Updated:March 18, 2020Completed
8
A Bioequivalence Study Of 4 Mg Fesoterodine Extended-Release Tablets (Toviaz™) In Healthy Subjects
Condition(s):Treatment of Overactive BladderLast Updated:October 16, 2018Completed
9
A Bioequivalence Study Of 8 Mg Fesoterodine Extended-Release Tablets (Toviaz™) In Healthy Subjects
Condition(s):Treatment of Overactive BladderLast Updated:September 28, 2018Completed
10
A Study to Compare the Effectiveness and Safety of Fesoterodine and Placebo in an Elderly Population of Patients Who go to the Toilet Very Frequently Due to Overactive Bladder.
Condition(s):Urinary Bladder, OveractiveLast Updated:December 14, 2011Completed